IDERA
Live / Registered — Registered and renewed (as of 24 Feb 2021)
What this means for you
Registered since 15 Sept 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Sept 2019).
Record
- Serial number
- 78660224
- Registration number
- 3684484
- Mark type
- Stylized text
- Filed
- 28 Jun 2005
- Published for opposition
- 31 Oct 2006
- Registered
- 15 Sept 2009
- Next maintenance due
- 15 Sept 2019
- Attorney of record
- Rebecca E. McDougall
Goods and services
- Class 005 — Pharmaceuticals: Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, [ biologically active antisense DNA or RNA compounds, ] chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
Owner
- IDERA PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- IDERA PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- IDERA PHARMACEUTICALS, INC., CAMBRIDGE, MA, US
- Hybridon, Inc., Cambridge, MA, US
Prosecution history
- 24 Feb 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 24 Feb 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 24 Feb 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 22 Feb 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 24 Aug 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 21 Aug 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Aug 2020 — REINSTATED
- 21 Aug 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Aug 2020 — PETITION TO DIRECTOR GRANTED
- 17 Aug 2020 — TEAS RESPONSE TO PETITION INQUIRY LETTER
- 29 Jul 2020 — PETITION INQUIRY LETTER ISSUED
- 28 Jul 2020 — ASSIGNED TO PETITION STAFF
- 06 Apr 2020 — TEAS PETITION TO DIRECTOR RECEIVED
- 27 Mar 2020 — NOTICE OF CANCELLATION SEC. 8 EMAILED
- 26 Mar 2020 — CANCELLED SEC. 8 (10-YR)